Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Ycanth™ (cantharidin) – New drug approval
July 21, 2023 - Verrica Pharmaceuticals announced the FDA approval of Ycanth (cantharidin), for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.
